Altered higher brain function in PACAP-knockout mice

Folia Pharmacologica Japonica

Volumn 123, Issue 4, 2004, Pages 274-280

  Shintani, Norihito ^a   Hashimoto, Hitoshi ^a   Baba, Akemichi ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Animal model; Knockout mouse; Neuropeptide; PACAP; Psychomotor behavior

Indexed keywords

AMPHETAMINE; HALOPERIDOL; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PHENCYCLIDINE; RISPERIDONE;

AMYGDALOID NUCLEUS; BRAIN CORTEX; BRAIN FUNCTION; BRAIN STEM; CEREBELLUM; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOREACTIVITY; JUMPING; KNOCKOUT MOUSE; LOCOMOTION; NONHUMAN; OLFACTORY BULB; PHENOTYPE; REVIEW; SPINAL CORD; THALAMUS; WILD TYPE;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; LONG-TERM POTENTIATION; MICE; MICE, KNOCKOUT; MUTATION; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PSYCHOMOTOR DISORDERS; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY HORMONE; REPRODUCTION;

EID: 1842787238     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.123.274     Document Type: Review

References (35)

1. Miyata A, Arimura A, Dahl RR, et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun. 1989;164:567-574.
2. Vaudry D, Gonzalez BJ, Basille M, Yon L, Fournier A, Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev. 2000;52:269-324.
3. Arimura A, Somogyvari-Vigh A, Miyata A, Mizuno K, Coy DH, Kitada C. Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology. 1991;129:2787-2789.
4. Hannibal J. Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study. J Comp Neurol. 2002;453:389-417.
5. Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron. 1992;8:811-819.
6. Inagaki N, Yoshida H, Mizuta M, et al. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc Natl Acad Sci U S A. 1994;91:2679-2683.
7. Hashimoto H, Ishihara T, Shigemoto R, Mori K, Nagata S. Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide. Neuron. 1993;11:333-342.
8. Basille M, Vaudry D, Coulouarn Y, et al. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development. J Comp Neurol. 2002;425:495-509.
9. Skoglosa Y, Takei N, Lindholm D. Distribution of pituitary adenylate cyclase activating polypeptide mRNA in the developing rat brain. Brain Res Mol Brain Res. 1999;65:1-13.
10. Waschek JA, Casillas RA, Nguyen TB, DiCicco-Bloom EM, Carpenter EM, Rodriguez WI. Neural tube expression of pituitary adenylate cyclase-activating peptide (PACAP) and receptor: potential role in patterning and neurogenesis. Proc Natl Acad Sci U S A. 1998;95:9602-9607.
11. Suh J, Lu N, Nicot A, Tatsuno I, DiCicco-Bloom E. PACAP is an anti-mitogenic signal in developing cerebral cortex. Nat Neurosci. 2001;4:123-124.
12. Telegdy G, Kokavszky K. The action of pituitary adenylate cyclase activating polypeptide (PACAP) on passive avoidance learning. The role of transmitters. Brain Res. 2000;874:194-199.
13. Sacchetti B, Lorenzini CA, Baldi E, et al. Pituitary adenylate cyclase-activating polypeptide hormone (PACAP) at very low dosages improves memory in the rat. Neurobiol Learn Mem. 2001;76:1-6.
14. Yada T, Sakurada M, Ihida K, et al. Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells. J Biol Chem. 1994;269:1290-1293.
15. Hashimoto H, Kunugi A, Arakawa N, et al. Possible involvement of a cyclic AMP-dependent mechanism in PACAP-induced proliferation and ERK activation in astrocytes. Biochem Biophys Res Commun. 2003;311:337-343.
16. Hashimoto H, Shintani N, Tanaka K, et al. Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci U S A. 2001;98:13355-13360.
17. Gray SL, Cummings KJ, Jirik FR, Sherwood NM. Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism. Mol Endocrinol. 2001;15:1739-1747.
18. Shintani N, Tomimoto S, Hashimoto H, Kawaguchi C, Baba A. Functional roles of the neuropeptide PACAP in brain and pancreas. Life Sci. 2003;74:337-343.
19. Otto C, Martin M, Wolfer DP, Lipp HP, Maldonado R, Schutz G. Altered emotional behavior in PACAP-type-I-receptor-deficient mice. Brain Res Mol Brain Res. 2001;92:78-84.
20. Rosse RB, Mastropaolo J, Sussman DM, Koetzner L, Morn CB, Deutsch SI. Computerized measurement of MK-801-elicited popping and hyperactivity in mice. Clin Neuropharmacol. 1995;18:448-457.
21. Mohn AR, Gainetdinov RR, Caron MG, Koller BH. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell. 1999;98:427-436.
22. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science. 1999;283:397-401.
23. Rojas K, Liang L, Johnson EI, Berrettini WH. Identification of candidate genes for psychiatric disorders on 18p11. Mol Psychiatry. 2000;5:389-395.
24. Kondo T, Tominaga T, Ichikawa M, Iijima T. Differential alteration of hippocampal synaptic strength induced by pituitary adenylate cyclase activating polypeptide-38 (PACAP-38). Neurosci Lett. 1997;221:189-192.
25. Hashimoto H, Shintani N, Nishino A, et al. Mice with markedly reduced PACAP (PAC (1)) receptor expression by targeted deletion of the signal peptide. J Neurochem. 2000;75:1810-1817.
26. Matsuyama S, Matsumoto A, Hashimoto H, Shintani N, Baba A. Impaired long-term potentiation in vivo in the dentate gyrus of pituitary adenylate cyclase-activating polypeptide (PACAP) or PACAP type 1 receptor-mutant mice. Neuroreport. 2003;14:2095-2098.
27. Feany MB, Quinn WG. A neuropeptide gene defined by the Drosophila memory mutant amnesiac. Science. 1995;268:869-873.
28. Shintani N, Mori W, Hashimoto H, et al. Defects in reproductive functions in PACAP-deficient female mice. Regul Pept. 2002;109:45-48.
29. Apostolakis EM, Lanz R, O'Malley BW. Pituitary adenylate cyclase-activating peptide: a pivotal modulator of steroid-induced reproductive behavior in female rodents. Mol Endocrinol. 2004;18:173-183.
30. Jamen F, Rodriguez-Henche N, Pralong F, et al. PAC1 null females display decreased fertility. Ann NY Acad Sci. 2000;921:400-404.
31. Kawaguchi C, Tanaka K, Isojima Y, et al. Changes in light-induced phase shift of circadian rhythm in mice lacking PACAP. Biochem Biophys Res Commun. 2003;310:169-175.
32. Hamelink C, Tjurmina O, Damadzic R, et al. Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis. Proc Natl Acad Sci U S A. 2002;99:461-466.
33. Gray SL, Yamaguchi N, Vencova P, Sherwood NM. Temperature-sensitive phenotype in mice lacking pituitary adenylate cyclase-activating polypeptide. Endocrinology. 2002;143:3946-3954.
34. Cummings KJ, Pendlebury JD, Sherwood NM, Wilson RJ. Sudden neonatal death in PACAP-deficient mice is associated with reduced respiratory chemoresponse and susceptibility to apnea. J Physiol. in press.